Katarina Ohrling
Rotkreuz, ZG 6943, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 22, 2025
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape.
Journal: Cancer treatment reviews
Published: December 22, 2023
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries.
Journal: Future oncology (London, England)
Published: November 30, 2023
Patient perception of burden of disease and treatment preferences in non-small cell lung cancer: Results from a European survey.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 01, 2021
On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 13, 2021
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 17, 2020
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European Countries.
Journal: Advances in therapy
Published: October 09, 2020
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives.
Journal: British journal of cancer
Published: March 17, 2020
Real-world use of talimogene laherparepvec in Germany: a retrospective observational study using a prescription database.
Journal: Future oncology (London, England)
Published: February 14, 2020
Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe.
Journal: European journal of dermatology : EJD
Published: January 31, 2019
Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey.
Journal: Advances in therapy
Published: October 16, 2018
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 09, 2018
Last Updated: 09/26/2026